Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Michael Kahn

Concepts (419)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
beta Catenin
17
2024
253
4.410
Why?
Electronic Health Records
22
2024
1046
2.620
Why?
Wnt Signaling Pathway
12
2024
192
2.160
Why?
Medical Informatics
6
2017
101
1.670
Why?
Data Accuracy
7
2024
65
1.580
Why?
Neoplastic Stem Cells
8
2021
399
1.530
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
2024
121
1.440
Why?
Medical Record Linkage
9
2024
64
1.390
Why?
Biomedical Research
9
2018
688
1.360
Why?
p300-CBP Transcription Factors
3
2018
26
1.240
Why?
CREB-Binding Protein
4
2018
31
1.210
Why?
Pediatrics
5
2019
1094
1.200
Why?
Catenins
2
2018
6
1.120
Why?
Crowding
3
2011
35
1.070
Why?
Health Services Research
3
2019
400
0.930
Why?
Pyrimidinones
7
2018
113
0.890
Why?
Computer Communication Networks
2
2014
33
0.880
Why?
Comparative Effectiveness Research
5
2017
150
0.870
Why?
Bridged Bicyclo Compounds, Heterocyclic
8
2018
227
0.860
Why?
Quality of Health Care
4
2013
634
0.790
Why?
Rare Diseases
1
2023
101
0.780
Why?
Imatinib Mesylate
2
2024
79
0.780
Why?
Data Warehousing
1
2022
5
0.770
Why?
Cloud Computing
1
2022
7
0.770
Why?
Glioma
2
2024
395
0.720
Why?
Patient-Centered Care
3
2014
522
0.670
Why?
Information Storage and Retrieval
5
2020
117
0.650
Why?
Clinical Trials as Topic
5
2017
1044
0.640
Why?
Quality Assurance, Health Care
3
2012
322
0.620
Why?
Machine Learning
2
2023
488
0.600
Why?
Genomic Instability
1
2018
53
0.570
Why?
gamma Catenin
1
2017
13
0.550
Why?
Urology
1
2018
63
0.550
Why?
Heterocyclic Compounds, 2-Ring
1
2017
12
0.540
Why?
Child Health
1
2019
154
0.530
Why?
Cyclic AMP Response Element-Binding Protein
1
2017
145
0.510
Why?
Humans
80
2025
136803
0.510
Why?
Hematopoiesis
1
2017
190
0.490
Why?
Radiation Injuries
1
2017
145
0.490
Why?
Medical Records Systems, Computerized
4
2012
92
0.490
Why?
Data Mining
2
2017
116
0.490
Why?
Databases, Factual
6
2019
1351
0.480
Why?
Child Welfare
2
2014
212
0.470
Why?
Evolution, Molecular
1
2018
488
0.440
Why?
Terminology as Topic
2
2014
216
0.440
Why?
Forms and Records Control
1
2013
23
0.430
Why?
Community Networks
1
2014
57
0.420
Why?
Quality Indicators, Health Care
3
2013
307
0.400
Why?
Quality Improvement
1
2021
1163
0.400
Why?
Population Surveillance
3
2020
474
0.380
Why?
Nursing Assessment
1
2011
57
0.350
Why?
Analgesia
1
2011
94
0.350
Why?
Embryonic Stem Cells
1
2011
123
0.350
Why?
Antineoplastic Agents
4
2021
2123
0.340
Why?
Wearable Electronic Devices
2
2021
53
0.340
Why?
Cell Line, Tumor
10
2024
3406
0.340
Why?
MicroRNAs
4
2021
692
0.330
Why?
Emergency Service, Hospital
2
2011
2048
0.320
Why?
Adverse Drug Reaction Reporting Systems
1
2010
77
0.320
Why?
Information Dissemination
3
2019
215
0.320
Why?
Models, Statistical
2
2019
668
0.320
Why?
Child
17
2020
21819
0.310
Why?
Pain
2
2011
755
0.310
Why?
Decision Support Systems, Clinical
2
2023
223
0.300
Why?
Accidental Falls
1
2011
193
0.290
Why?
United States
18
2022
14691
0.290
Why?
Mice
15
2024
17759
0.290
Why?
Luciferases
2
2019
149
0.290
Why?
Mass Screening
2
2020
1267
0.290
Why?
Heart Defects, Congenital
3
2020
833
0.290
Why?
Animals
20
2024
36850
0.280
Why?
Algorithms
5
2024
1690
0.270
Why?
Organizational Policy
1
2007
82
0.260
Why?
Pain Management
2
2025
348
0.260
Why?
Pregnenes
1
2006
1
0.260
Why?
Fluorine
1
2006
16
0.260
Why?
Diabetes Mellitus, Type 2
5
2020
2518
0.250
Why?
Cell Differentiation
3
2024
1982
0.250
Why?
Pain Clinics
1
2025
4
0.240
Why?
Pain, Postoperative
2
2025
266
0.240
Why?
Emergency Medical Services
1
2011
547
0.240
Why?
Transitional Care
1
2025
40
0.230
Why?
Patient Care Team
2
2025
626
0.230
Why?
Neoplasms
2
2017
2643
0.230
Why?
Receptors, Glucocorticoid
1
2006
155
0.220
Why?
Biological Science Disciplines
1
2024
17
0.220
Why?
Knowledge Bases
1
2024
27
0.220
Why?
Wnt Proteins
3
2016
133
0.220
Why?
Adolescent
16
2022
21385
0.220
Why?
Diabetes Mellitus, Type 1
5
2020
3710
0.220
Why?
Analgesics, Opioid
3
2025
993
0.210
Why?
Pattern Recognition, Automated
1
2024
73
0.210
Why?
Child, Preschool
9
2020
10997
0.210
Why?
Prostatic Neoplasms, Castration-Resistant
1
2024
50
0.210
Why?
Time Factors
5
2025
6809
0.210
Why?
Phenotype
3
2023
3189
0.200
Why?
Pyrazoles
1
2006
423
0.200
Why?
Tumor Microenvironment
2
2024
672
0.190
Why?
Pyridines
1
2006
506
0.190
Why?
Adrenal Cortex Hormones
1
2006
556
0.190
Why?
Androgens
1
2024
187
0.190
Why?
Data Collection
3
2014
668
0.190
Why?
Precision Medicine
2
2024
426
0.190
Why?
Mouth Neoplasms
1
2023
120
0.190
Why?
Cell Movement
4
2023
968
0.180
Why?
Infant
7
2020
9395
0.180
Why?
Receptors, Tumor Necrosis Factor
1
2022
164
0.180
Why?
Life Cycle Stages
1
2021
41
0.180
Why?
Asthma
3
2011
2282
0.180
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2017
288
0.180
Why?
Hyaluronan Receptors
2
2018
103
0.180
Why?
Reactive Oxygen Species
1
2024
621
0.170
Why?
MDS1 and EVI1 Complex Locus Protein
1
2020
8
0.170
Why?
Education, Distance
1
2021
48
0.170
Why?
Recurrence
1
2024
1055
0.170
Why?
Carcinoma, Hepatocellular
2
2022
361
0.170
Why?
Tumor Stem Cell Assay
2
2018
34
0.170
Why?
Molecular Targeted Therapy
3
2021
411
0.160
Why?
Drug Resistance, Neoplasm
4
2021
800
0.160
Why?
Chromatin
1
2024
519
0.160
Why?
India
4
2020
193
0.160
Why?
Colorado
8
2024
4515
0.160
Why?
Organ Transplantation
1
2022
248
0.160
Why?
Information Services
1
2019
49
0.160
Why?
Information Management
2
2012
18
0.160
Why?
Young Adult
8
2020
13129
0.150
Why?
Immunotherapy
1
2024
640
0.150
Why?
Sentinel Surveillance
2
2018
48
0.150
Why?
Cell Proliferation
5
2023
2476
0.150
Why?
Nerve Tissue Proteins
1
2023
595
0.150
Why?
Penicillin Resistance
1
1998
8
0.150
Why?
Cell Cycle Proteins
1
2023
613
0.150
Why?
Opioid-Related Disorders
2
2025
509
0.150
Why?
Non-alcoholic Fatty Liver Disease
1
2022
279
0.150
Why?
Acute Disease
2
2011
1007
0.150
Why?
Proto-Oncogene Proteins B-raf
1
2020
224
0.150
Why?
Male
17
2025
67330
0.150
Why?
Metabolic Syndrome
1
2022
354
0.140
Why?
Adult
12
2025
37643
0.140
Why?
Female
18
2025
72816
0.140
Why?
Colorectal Neoplasms
2
2020
791
0.140
Why?
Reproducibility of Results
4
2021
3265
0.140
Why?
Toxicity Tests
1
2018
37
0.140
Why?
Cisplatin
2
2021
320
0.140
Why?
Liver Neoplasms
2
2022
785
0.140
Why?
Neoplasm Recurrence, Local
1
2024
1058
0.140
Why?
Infant, Newborn
5
2020
6032
0.140
Why?
Pneumococcal Infections
1
1998
115
0.140
Why?
Pragmatic Clinical Trials as Topic
1
2017
64
0.140
Why?
Proto-Oncogene Proteins
1
2021
647
0.140
Why?
Datasets as Topic
1
2017
119
0.140
Why?
Diabetic Ketoacidosis
1
2020
200
0.140
Why?
Research Design
4
2021
1127
0.140
Why?
National Institutes of Health (U.S.)
1
2017
128
0.130
Why?
Fractures, Bone
2
2011
376
0.130
Why?
Pain Measurement
2
2025
521
0.130
Why?
E1A-Associated p300 Protein
1
2016
11
0.120
Why?
Hospitals, University
2
2011
182
0.120
Why?
Xenograft Model Antitumor Assays
2
2017
868
0.120
Why?
Cross Infection
1
1998
250
0.120
Why?
Cross-Sectional Studies
3
2011
5424
0.120
Why?
Vocabulary, Controlled
2
2014
47
0.120
Why?
Adult Stem Cells
1
2016
39
0.120
Why?
Logistic Models
2
2011
2067
0.120
Why?
Acute Kidney Injury
1
2023
809
0.120
Why?
Immunotherapy, Adoptive
1
2019
321
0.120
Why?
Product Surveillance, Postmarketing
1
2015
63
0.120
Why?
Ovarian Neoplasms
1
2021
562
0.110
Why?
Antigens, CD
1
2018
521
0.110
Why?
Neoplasm Proteins
1
2018
434
0.110
Why?
Protein Kinase C
1
2016
261
0.110
Why?
Receptors, Notch
1
2015
88
0.110
Why?
Program Development
2
2019
364
0.110
Why?
Hospitals, Pediatric
1
2017
505
0.110
Why?
Hydronephrosis
1
2014
36
0.110
Why?
Renin-Angiotensin System
1
2014
84
0.110
Why?
Epithelial-Mesenchymal Transition
2
2015
209
0.110
Why?
Database Management Systems
2
2012
51
0.110
Why?
Hedgehog Proteins
1
2015
195
0.110
Why?
Hematopoietic Stem Cells
1
2017
402
0.110
Why?
Ubiquitin-Protein Ligases
1
2015
176
0.110
Why?
Organizational Innovation
1
2014
138
0.100
Why?
Biomarkers, Tumor
2
2018
1272
0.100
Why?
Cardiovascular Surgical Procedures
1
2013
30
0.100
Why?
Gene Expression Regulation, Neoplastic
4
2023
1396
0.100
Why?
Interinstitutional Relations
1
2013
53
0.100
Why?
Chronic Disease
1
2019
1786
0.100
Why?
Odds Ratio
2
2011
1066
0.100
Why?
Patient Handoff
1
2013
32
0.100
Why?
Patient Identification Systems
1
2013
16
0.100
Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
250
0.100
Why?
Signal Transduction
4
2015
5077
0.100
Why?
Cell Line
5
2019
2838
0.100
Why?
Models, Theoretical
2
2017
575
0.100
Why?
Cells, Cultured
2
2018
4192
0.100
Why?
Postoperative Period
1
2013
343
0.100
Why?
Retrospective Studies
6
2022
15510
0.100
Why?
Multicenter Studies as Topic
1
2013
308
0.090
Why?
Ethics Committees, Research
1
2012
41
0.090
Why?
TCF Transcription Factors
1
2011
17
0.090
Why?
Documentation
1
2013
191
0.090
Why?
Registries
4
2020
2015
0.090
Why?
Risk Assessment
2
2011
3434
0.090
Why?
Mice, Transgenic
1
2017
2163
0.090
Why?
Operating Rooms
1
2013
123
0.090
Why?
Diabetes Mellitus
1
2020
1033
0.090
Why?
Narcotics
1
2011
52
0.090
Why?
Inhibitor of Apoptosis Proteins
1
2011
49
0.090
Why?
Bed Occupancy
1
2011
16
0.090
Why?
Research
1
2014
448
0.090
Why?
Confidence Intervals
1
2011
328
0.090
Why?
Transforming Growth Factor beta1
1
2012
165
0.090
Why?
Protein Interaction Domains and Motifs
1
2011
150
0.090
Why?
Protein Binding
1
2017
2216
0.090
Why?
Joint Commission on Accreditation of Healthcare Organizations
1
2010
9
0.080
Why?
Structure-Activity Relationship
2
2014
570
0.080
Why?
Heart Failure
1
2023
2231
0.080
Why?
Intensive Care Units, Pediatric
1
2012
233
0.080
Why?
Ambulatory Care
1
2014
539
0.080
Why?
Intubation, Intratracheal
1
2012
257
0.080
Why?
Cell Lineage
1
2011
347
0.080
Why?
Child, Hospitalized
1
2010
49
0.080
Why?
Injury Severity Score
1
2011
521
0.080
Why?
Analgesics
1
2011
206
0.080
Why?
Patient Safety
1
2013
308
0.080
Why?
Needs Assessment
1
2011
372
0.080
Why?
Cooperative Behavior
1
2012
445
0.080
Why?
Radiography
1
2011
822
0.080
Why?
RNA, Small Interfering
3
2018
622
0.080
Why?
Workflow
1
2010
165
0.070
Why?
Overweight
1
2013
557
0.070
Why?
Age of Onset
2
2020
518
0.070
Why?
Pilot Projects
1
2013
1693
0.070
Why?
Computational Biology
3
2019
643
0.070
Why?
Pulmonary Fibrosis
1
2012
399
0.070
Why?
Intensive Care Units
1
2013
800
0.070
Why?
Gene Expression Regulation
2
2014
2605
0.070
Why?
Anti-Asthmatic Agents
1
2011
393
0.070
Why?
Multivariate Analysis
1
2011
1507
0.070
Why?
Internet
1
2012
647
0.070
Why?
Inpatients
1
2011
496
0.060
Why?
Stereoisomerism
1
2006
96
0.060
Why?
Pediatric Obesity
1
2013
590
0.060
Why?
Microwaves
1
2006
37
0.060
Why?
Brain Neoplasms
1
2015
1235
0.060
Why?
Down-Regulation
2
2021
656
0.060
Why?
Mutation
3
2022
3947
0.060
Why?
Epithelial Cells
1
2012
1094
0.060
Why?
Ambulatory Care Information Systems
1
2005
5
0.060
Why?
Transcription, Genetic
1
2011
1455
0.060
Why?
Ontario
1
2025
157
0.060
Why?
Indiana
1
2024
33
0.060
Why?
Molecular Structure
1
2006
489
0.060
Why?
Aqueous Humor
2
1983
34
0.060
Why?
Positron-Emission Tomography
1
2006
293
0.060
Why?
Patient Readmission
1
2010
694
0.060
Why?
Hepatocyte Growth Factor
1
2024
35
0.050
Why?
Evidence-Based Medicine
1
2008
739
0.050
Why?
Glycogen Storage Disease Type I
1
2023
6
0.050
Why?
HEK293 Cells
2
2018
729
0.050
Why?
Active Transport, Cell Nucleus
1
2024
123
0.050
Why?
Ribosomal Proteins
1
2024
93
0.050
Why?
Healthcare Disparities
1
2010
649
0.050
Why?
Androgen Antagonists
1
2024
82
0.050
Why?
Mice, Nude
2
2015
696
0.050
Why?
Hospitals, General
1
2022
22
0.050
Why?
Biological Specimen Banks
1
2024
102
0.050
Why?
Trabecular Meshwork
1
1983
79
0.050
Why?
Receptors, Androgen
1
2024
150
0.050
Why?
Exercise
1
2014
2044
0.050
Why?
Prevalence
2
2019
2710
0.050
Why?
Kinetics
1
2006
1664
0.050
Why?
Health Services Accessibility
1
2010
978
0.050
Why?
Health Insurance Portability and Accountability Act
1
2022
13
0.050
Why?
Middle Aged
5
2025
33239
0.050
Why?
Bronchial Diseases
1
2002
37
0.050
Why?
Serine Proteinase Inhibitors
1
2002
47
0.050
Why?
Immune Evasion
1
2022
58
0.050
Why?
Glutathione
1
1983
356
0.050
Why?
Glucocorticoids
1
2006
593
0.050
Why?
Hepatitis B
1
2022
70
0.050
Why?
Appointments and Schedules
1
2002
89
0.040
Why?
Serine Endopeptidases
1
2002
123
0.040
Why?
Fitness Trackers
1
2021
12
0.040
Why?
Sensitivity and Specificity
1
2006
1936
0.040
Why?
Collagen
1
2023
446
0.040
Why?
Fibrosis
1
2023
552
0.040
Why?
Promoter Regions, Genetic
2
2016
1249
0.040
Why?
Clinical Protocols
1
2002
267
0.040
Why?
Insurance Claim Reporting
1
2020
24
0.040
Why?
Piperidines
1
2002
206
0.040
Why?
Microsatellite Repeats
1
2020
168
0.040
Why?
Neoplasm Grading
1
2021
305
0.040
Why?
3' Untranslated Regions
1
2020
145
0.040
Why?
Prospective Studies
3
2020
7573
0.040
Why?
Probability
1
2020
304
0.040
Why?
Receptors, Antigen
1
2019
16
0.040
Why?
Tumor Cells, Cultured
1
2021
953
0.040
Why?
Demography
1
2020
291
0.040
Why?
Bias
1
2020
218
0.040
Why?
Missouri
1
1998
61
0.040
Why?
Gene Expression
2
2016
1500
0.040
Why?
Cohort Studies
2
2022
5704
0.040
Why?
Genomics
1
2024
790
0.040
Why?
Artificial Intelligence
1
2002
275
0.040
Why?
Consumer Product Safety
1
2018
33
0.040
Why?
Surveys and Questionnaires
2
2021
5744
0.040
Why?
Computer Systems
1
2018
45
0.040
Why?
Linear Models
1
2019
846
0.030
Why?
Prognosis
2
2020
4013
0.030
Why?
Lymphocytes
1
2019
393
0.030
Why?
Mice, Knockout
2
2016
3009
0.030
Why?
Mice, Inbred BALB C
2
2014
1269
0.030
Why?
Community-Acquired Infections
1
1998
169
0.030
Why?
Aquaporin 5
1
2016
3
0.030
Why?
Recombinant Fusion Proteins
1
2019
664
0.030
Why?
Wnt-5a Protein
1
2016
23
0.030
Why?
Electric Impedance
1
2016
107
0.030
Why?
Students
1
2021
624
0.030
Why?
Nasopharyngeal Neoplasms
1
2015
21
0.030
Why?
Flow Cytometry
1
2019
1180
0.030
Why?
Predictive Value of Tests
1
2020
2022
0.030
Why?
Alveolar Epithelial Cells
1
2016
114
0.030
Why?
Ubiquitination
1
2015
102
0.030
Why?
Transplantation, Heterologous
1
2015
194
0.030
Why?
SOXB1 Transcription Factors
1
2015
61
0.030
Why?
Health Planning Guidelines
1
2014
25
0.030
Why?
Receptors, Antigen, T-Cell
1
2019
718
0.030
Why?
Inhibitory Concentration 50
1
2014
90
0.030
Why?
Drug Synergism
1
2015
383
0.030
Why?
Herpesvirus 4, Human
1
2015
167
0.030
Why?
Calibration
1
2014
146
0.030
Why?
Proteinuria
1
2014
97
0.030
Why?
Drug Design
1
2015
167
0.030
Why?
Microscopy, Confocal
1
2015
324
0.030
Why?
Semantics
1
2014
92
0.030
Why?
Albumins
1
2014
113
0.030
Why?
Podocytes
1
2014
63
0.030
Why?
Kidney Tubules
1
2014
117
0.030
Why?
Pandemics
1
2022
1616
0.030
Why?
ras Proteins
1
2014
153
0.030
Why?
RNA Interference
1
2015
466
0.030
Why?
Protein Processing, Post-Translational
1
2016
465
0.030
Why?
Drug Discovery
1
2014
141
0.030
Why?
Incidence
1
2020
2797
0.030
Why?
Names
1
2013
14
0.030
Why?
Carcinoma
1
2015
238
0.030
Why?
Systems Integration
1
2013
37
0.030
Why?
Aged
2
2025
23808
0.030
Why?
Follow-Up Studies
2
2014
5106
0.020
Why?
Tumor Suppressor Proteins
1
2015
327
0.020
Why?
Quality Control
1
2013
171
0.020
Why?
Research Personnel
1
2014
171
0.020
Why?
Airway Extubation
1
2013
57
0.020
Why?
Creatinine
1
2014
499
0.020
Why?
Ligands
1
2014
661
0.020
Why?
Smad3 Protein
1
2012
43
0.020
Why?
Medical Errors
1
2013
112
0.020
Why?
Phosphorylation
1
2016
1758
0.020
Why?
Gene Targeting
1
2011
81
0.020
Why?
Oxygen Consumption
1
2014
695
0.020
Why?
Binding Sites
1
2014
1301
0.020
Why?
RNA, Messenger
1
2018
2831
0.020
Why?
Quality of Life
1
2022
2878
0.020
Why?
Neoplasm, Residual
1
2011
133
0.020
Why?
T-Lymphocytes
1
2019
1993
0.020
Why?
Oligonucleotides
1
2011
148
0.020
Why?
Academic Medical Centers
1
2013
504
0.020
Why?
Longitudinal Studies
1
2017
2829
0.020
Why?
Feasibility Studies
1
2014
951
0.020
Why?
Zebrafish
1
2014
495
0.020
Why?
Actins
1
2012
416
0.020
Why?
Mice, Inbred NOD
1
2011
600
0.020
Why?
Respiration, Artificial
1
2013
642
0.020
Why?
Combined Modality Therapy
1
2011
1231
0.020
Why?
Repressor Proteins
1
2011
427
0.020
Why?
Rats
1
2016
5639
0.020
Why?
Kidney
1
2014
1467
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1684
0.020
Why?
Treatment Outcome
1
2020
10748
0.010
Why?
Practice Guidelines as Topic
1
2013
1572
0.010
Why?
Information Centers
1
2005
4
0.010
Why?
Hospitals
1
2010
684
0.010
Why?
Databases as Topic
1
2005
67
0.010
Why?
Body Mass Index
1
2013
2375
0.010
Why?
Practice Patterns, Physicians'
1
2013
1301
0.010
Why?
Diamide
1
1983
5
0.010
Why?
Disease Models, Animal
1
2014
4282
0.010
Why?
Iodoacetates
1
1983
3
0.010
Why?
Iodoacetamide
1
1983
5
0.010
Why?
Ethylmaleimide
1
1983
18
0.010
Why?
Carmustine
1
1983
50
0.010
Why?
Sulfhydryl Reagents
1
1983
12
0.010
Why?
Anterior Chamber
1
1983
22
0.010
Why?
Free Radicals
1
1983
110
0.010
Why?
Biomarkers
1
2014
4145
0.010
Why?
Tryptases
1
2002
13
0.010
Why?
Vascular Cell Adhesion Molecule-1
1
2002
39
0.010
Why?
Rabbits
1
1983
792
0.010
Why?
Pulmonary Eosinophilia
1
2002
27
0.010
Why?
Lens, Crystalline
1
1983
125
0.010
Why?
Hydrogen Peroxide
1
1983
327
0.010
Why?
Time
1
2002
82
0.010
Why?
Ovalbumin
1
2002
183
0.010
Why?
Pulmonary Edema
1
2002
107
0.010
Why?
Mucus
1
2002
79
0.010
Why?
Bronchial Hyperreactivity
1
2002
111
0.010
Why?
Cattle
1
1983
981
0.010
Why?
Amino Acids
1
1983
497
0.010
Why?
Oxidation-Reduction
1
1983
1059
0.010
Why?
Eosinophils
1
2002
332
0.010
Why?
Bronchoalveolar Lavage Fluid
1
2002
655
0.010
Why?
Glucose
1
1983
1019
0.010
Why?
Risk Factors
1
2012
10332
0.010
Why?
Decision Support Techniques
1
2002
418
0.010
Why?
Models, Molecular
1
2002
1570
0.010
Why?
Cytokines
1
2002
2084
0.010
Why?
Inflammation
1
2002
2835
0.010
Why?
Lung
1
2002
4063
0.000
Why?
Kahn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)